Does homeostasis model assessment of insulin resistance have a predictive value for post-coronary artery bypass grafting surgery outcomes?
- PMID: 25372910
- PMCID: PMC4412326
- DOI: 10.5935/1678-9741.20140105
Does homeostasis model assessment of insulin resistance have a predictive value for post-coronary artery bypass grafting surgery outcomes?
Abstract
Objective: This study aims to investigate whether pre-operative Homeostasis Model Assessment Insulin Resistance (HOMA-IR) value is a predictor in non-diabetic coronary artery bypass grafting patients in combination with hemoglobin A1c, fasting blood glucose and insulin levels.
Methods: Eighty one patients who were admitted to Cardiovascular Surgery Clinic at our hospital between August 2012 and January 2013 with a coronary artery bypass grafting indication were included. Patients were non-diabetic with <6.3% hemoglobin A1c and were divided into two groups including treatment and control groups according to normal insulin resistance (HOMA-IR<2.5, Group A; n=41) and high insulin resistance (HOMA-IR>2.5, Group B; n=40), respectively. Pre-operative fasting blood glucose and insulin were measured and serum chemistry tests were performed. The Homeostasis Model Assessment Insulin Resistance values were calculated. Statistical analysis was performed.
Results: There was a statistically significant difference in fasting blood glucose and HOMA-IR values between the groups. Cross-clamping time, and cardiopulmonary bypass time were longer in Group B, compared to Group A (P=0.043 and P=0.031, respectively). Logistic regression analysis revealed that hemoglobin A1c was not a reliable determinant factor alone for pre-operative glucometabolic evaluation of non-diabetic patients. The risk factors of fasting blood glucose and cardiopulmonary bypass time were more associated with high Homeostasis Model Assessment Insulin Resistance levels.
Conclusion: Our study results suggest that preoperative screening of non-diabetic patients with Homeostasis Model Assessment Insulin Resistance may improve both follow-up visit schedule and short-term outcomes, and may be useful in risk stratification of the high-risk population for impending health problems.
Objetivo: Este estudo tem como objetivo investigar se a resistência de valor do Modelo de Avaliação da Homeostase da Resistência à Insulina (Homeostasis Model Assessment Insulin Resistance - HOMA-IR) no pré-operatório é um preditor de revascularização do miocárdio para pacientes não diabéticos em combinação com a hemoglobina A1c, glicemia em jejum e insulina.
Métodos: Oitenta e um pacientes que foram internados no serviço de Cirurgia Cardiovascular em nosso hospital entre agosto de 2012 e janeiro de 2013, com indicação para cirurgia de revascularização do miocárdio indicação foram incluídos. Os pacientes não diabéticos com <6,3% de hemoglobina A1c foram divididos em dois grupos, incluindo os grupos de tratamento e controle de acordo com a resistência à insulina normal (HOMA-IR <2,5, Grupo A, n=41) e alta resistência à insulina (HOMA-IR> 2,5, Grupo B, n=40), respectivamente. Glicemia de jejum pré-operatório e insulina foram medidas e testes de química do soro foram realizados. Os valores de HOMA-IR foram calculados. A análise estatística foi realizada.
Resultados: Houve diferença estatisticamente significativa em jejum de valores de glicose no sangue e HOMA-IR entre os grupos. Tempo de pinçamento e tempo de circulação extracorpórea foi maior no grupo B, em relação ao Grupo A (P=0,043 e P=0,031, respectivamente). A análise de regressão logística revelou que hemoglobina A1c não foi um fator determinante para a avaliação confiável sozinho glicometabólico pré-operatória de pacientes não diabéticos. Os fatores de risco de glicemia de jejum e tempo de circulação extracorpórea foram associados com altos níveis do HOMA-IR.
Conclusão: Nossos resultados sugerem que a triagem pré-operatória de pacientes não diabéticos utilizando o HOMA-IR pode melhorar tanto o cronograma de acompanhamento quanto resultados de curto prazo, e pode ser útil na estratificação da população de alto risco para iminentes problemas de saúde.
Similar articles
-
Impact of Insulin Resistance on Acetylcholine-Induced Coronary Artery Spasm in Non-Diabetic Patients.Yonsei Med J. 2018 Nov;59(9):1057-1063. doi: 10.3349/ymj.2018.59.9.1057. Yonsei Med J. 2018. PMID: 30328320 Free PMC article.
-
Diagnostic value of hemoglobin A1c and fasting plasma glucose levels in coronary artery bypass grafting patients with undiagnosed diabetes mellitus.Ann Thorac Surg. 2010 May;89(5):1482-7. doi: 10.1016/j.athoracsur.2009.11.033. Ann Thorac Surg. 2010. PMID: 20417764
-
Relationship of Insulin Resistance to Prevalence and Progression of Coronary Artery Calcification Beyond Metabolic Syndrome Components: Shiga Epidemiological Study of Subclinical Atherosclerosis.Arterioscler Thromb Vasc Biol. 2016 Aug;36(8):1703-8. doi: 10.1161/ATVBAHA.116.307612. Epub 2016 Jun 9. Arterioscler Thromb Vasc Biol. 2016. PMID: 27283744
-
A meta-analysis of the effect of angiotensin receptor blockers and calcium channel blockers on blood pressure, glycemia and the HOMA-IR index in non-diabetic patients.Metabolism. 2013 Dec;62(12):1858-66. doi: 10.1016/j.metabol.2013.08.008. Epub 2013 Sep 16. Metabolism. 2013. PMID: 24050270 Review.
-
Association between the homeostasis model assessment of insulin resistance and coronary artery calcification: a meta-analysis of observational studies.Front Endocrinol (Lausanne). 2023 Nov 27;14:1271857. doi: 10.3389/fendo.2023.1271857. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 38089605 Free PMC article.
Cited by
-
Exploring the Link between the Components of Metabolic Syndrome and the Risk of Depression.Biomed Res Int. 2015;2015:586251. doi: 10.1155/2015/586251. Epub 2015 Dec 7. Biomed Res Int. 2015. PMID: 26770976 Free PMC article.
-
Prognostic Value of the Leuko-Glycaemic Index in the Postoperative Period of Coronary Artery Bypass Grafting.Braz J Cardiovasc Surg. 2021 Aug 6;36(4):484-491. doi: 10.21470/1678-9741-2020-0349. Braz J Cardiovasc Surg. 2021. PMID: 34236791 Free PMC article.
-
Screening for Glucose Metabolism Disorders, Assessment the Disse Insulin Resistance Index and Hospital Prognosis of Coronary Artery Bypass Surgery.J Pers Med. 2021 Aug 17;11(8):802. doi: 10.3390/jpm11080802. J Pers Med. 2021. PMID: 34442446 Free PMC article.
-
The Role of Insulin Resistance in the Development of Complications after Coronary Artery Bypass Grafting in Patients with Coronary Artery Disease.Biomedicines. 2023 Nov 5;11(11):2977. doi: 10.3390/biomedicines11112977. Biomedicines. 2023. PMID: 38001977 Free PMC article.
-
The Comparison of Irisin, Subfatin, and Adropin in Normal-Weight and Obese Polycystic Ovary Syndrome Patients.Iran J Med Sci. 2024 Jun 1;49(6):350-358. doi: 10.30476/ijms.2023.99130.3117. eCollection 2024 Jun. Iran J Med Sci. 2024. PMID: 38952638 Free PMC article.
References
-
- Emerging Risk Factors Collaboration. Sarwar N, Gao P, Seshasai SR, Gobin R, Kaptoge S, Di Angelantonio E, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375(9733):2215–2222. - PMC - PubMed
-
- Sarwar N, Sattar N, Gudnason V, Danesh J. Circulating concentrations of insulin markers and coronary heart disease: a quantitative review of 19 Western prospective studies. Eur Heart J. 2007;28(20):2491–2497. - PubMed
-
- Yu Q, Gao F, Ma XL. Insulin says NO to cardiovascular disease. Cardiovasc Res. 2011;89(3):516–524. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical